Search results
Results from the WOW.Com Content Network
Infant respiratory distress syndrome (IRDS), also known as surfactant deficiency disorder (SDD), [2] and previously called hyaline membrane disease (HMD), is a syndrome in premature infants caused by developmental insufficiency of pulmonary surfactant production and structural immaturity in the lungs.
Transient tachypnea of the newborn is a respiratory problem that can be seen in the newborn shortly after delivery. It is caused by retained fetal lung fluid due to impaired clearance mechanisms. [1] It is the most common cause of respiratory distress in term neonates.
768.3 Fetal distress, during labor, in infant; 768.5 Birth asphyxia, severe; 768.9 Birth asphyxia, unspec. 769 Respiratory distress syndrome; 770 Other respiratory conditions of fetus and newborn. 770.1 Meconium aspiration syndrome
Bronchopulmonary dysplasia (BPD; part of the spectrum of chronic lung disease of infancy) is a chronic lung disease which affects premature infants.Premature (preterm) infants who require treatment with supplemental oxygen or require long-term oxygen are at a higher risk. [1]
The results were as follows: Respiratory distress occurred in 22/23 of THAN patients and only in 0/13 of UCED patients. [6] Abnormal chest radiographs were found in 23/25 THAN victims, and 0/9 in UCED patients. [6] The gestational age was less than 36 weeks in 25/31 THAN patients, but only 1/13 UCED patients. [6]
Infant respiratory distress syndrome is a common complication of neonatal infection, a condition that causes difficulty breathing in preterm neonates. Respiratory distress syndrome can arise following neonatal infection, and this syndrome may have long-term negative consequences.
Meconium aspiration syndrome (MAS), also known as neonatal aspiration of meconium, is a medical condition affecting newborn infants.It describes the spectrum of disorders and pathophysiology of newborns born in meconium-stained amniotic fluid (MSAF) and have meconium within their lungs.
Acute respiratory distress syndrome was first described in 1967 by Ashbaugh et al. [10] [50] Initially there was no clearly established definition, which resulted in controversy regarding the incidence and death of ARDS. In 1988, an expanded definition was proposed, which quantified physiologic respiratory impairment.